Business Description

Description
HeraMED Ltd is engaged in developing innovative, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heart beat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR).

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 4.06
Equity-to-Asset 0.23
Debt-to-Equity 0.38
Debt-to-EBITDA -0.05
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -25.24
Distress
Grey
Safe
Beneish M-Score -3.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 30.19
9-Day RSI 38.71
14-Day RSI 42.02
6-1 Month Momentum % -63.35
12-1 Month Momentum % -81.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.28
Quick Ratio 1.04
Cash Ratio 0.7
Days Inventory 487.68
Days Sales Outstanding 175.72
Days Payable 1375.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -28.9
Shareholder Yield % -0.06

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 60.07
Operating Margin % -1100.17
Net Margin % -1117.97
FCF Margin % -942.6
ROE % -332.57
ROA % -157.66
ROIC % -340.47
ROC (Joel Greenblatt) % -5862.02
ROCE % -236.64

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 8.75
PB Ratio 8.75
EV-to-EBIT -0.81
EV-to-EBITDA -0.9
EV-to-Revenue 8.87
EV-to-FCF -0.94
Earnings Yield (Greenblatt) % -123.55
FCF Yield % -91.64

Financials

ASX:HMD's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

HeraMED Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0.601
EPS (TTM) (A$) -0.025
Beta 1.7
Volatility % 56.53
14-Day RSI 42.02
14-Day ATR (A$) 0.000487
20-Day SMA (A$) 0.017975
12-1 Month Momentum % -81.5
52-Week Range (A$) 0.012 - 0.102717
Shares Outstanding (Mil) 353.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HeraMED Ltd Filings

Filing Date Document Date Form
No Filing Data

HeraMED Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

HeraMED Ltd Frequently Asked Questions

What is HeraMED Ltd(ASX:HMD)'s stock price today?
The current price of ASX:HMD is A$0.02. The 52 week high of ASX:HMD is A$0.10 and 52 week low is A$0.01.
When is next earnings date of HeraMED Ltd(ASX:HMD)?
The next earnings date of HeraMED Ltd(ASX:HMD) is .
Does HeraMED Ltd(ASX:HMD) pay dividends? If so, how much?
HeraMED Ltd(ASX:HMD) does not pay dividend.

Press Release

Subject Date
No Press Release